> top > docs > PMC:1920263 > spans > 4396-4630 > annotations

PMC:1920263 / 4396-4630 JSONTXT

Annnotations TAB JSON ListView MergeView

GO-CC

Id Subject Object Predicate Lexical cue
T2583 12-16 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T2584 71-75 http://purl.obolibrary.org/obo/GO_0005623 denotes cell

UBERON-AE

Id Subject Object Predicate Lexical cue
T2309 173-178 http://purl.obolibrary.org/obo/UBERON_0001977 denotes serum

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T2446 0-3 DT denotes The
T2447 4-9 JJ denotes human
T2448 10-11 NNP denotes T
T2449 12-16 NN denotes cell
T2450 17-22 NNS denotes lines
T2451 23-25 VBP denotes A3
T2452 25-28 CD denotes .01
T2453 29-32 CC denotes and
T2454 33-36 NNP denotes PM1
T2455 37-38 -LRB- denotes (
T2456 38-43 NNP denotes NIBSC
T2457 43-44 , denotes ,
T2458 45-47 NNP denotes UK
T2459 47-48 -RRB- denotes )
T2460 49-52 CC denotes and
T2461 53-56 DT denotes the
T2462 57-62 JJ denotes human
T2463 63-70 JJ denotes myeloid
T2464 71-75 NN denotes cell
T2465 76-80 NN denotes line
T2466 81-85 NNP denotes U937
T2467 86-87 -LRB- denotes (
T2468 87-92 NNP denotes NIBSC
T2469 92-93 , denotes ,
T2470 94-96 NNP denotes UK
T2471 96-97 -RRB- denotes )
T2472 98-102 VBD denotes were
T2473 103-108 VBN denotes grown
T2474 109-111 IN denotes in
T2475 112-120 JJ denotes complete
T2476 121-125 NNP denotes RPMI
T2477 126-130 CD denotes 1640
T2478 131-137 JJ denotes medium
T2479 138-150 VBN denotes supplemented
T2480 151-155 IN denotes with
T2481 156-158 CD denotes 10
T2482 158-159 NN denotes %
T2483 160-165 JJ denotes fetal
T2484 166-172 JJ denotes bovine
T2485 173-178 NN denotes serum
T2486 178-179 , denotes ,
T2487 180-181 CD denotes 2
T2488 182-184 NNP denotes mM
T2489 185-196 NN denotes l-glutamine
T2490 197-200 CC denotes and
T2491 201-204 CD denotes 100
T2492 205-209 JJ denotes U/ml
T2493 210-220 NN denotes penicillin
T2494 221-233 NN denotes streptomycin
T2495 233-234 . denotes .
R1992 T2446 T2450 det The,lines
R1993 T2447 T2450 amod human,lines
R1994 T2448 T2449 compound T,cell
R1995 T2449 T2450 compound cell,lines
R1996 T2450 T2451 nsubj lines,A3
R1997 T2451 T2451 ROOT A3,A3
R1998 T2452 T2451 dobj .01,A3
R1999 T2453 T2452 cc and,.01
R2000 T2454 T2452 conj PM1,.01
R2001 T2455 T2456 punct (,NIBSC
R2002 T2456 T2454 appos NIBSC,PM1
R2003 T2457 T2456 punct ",",NIBSC
R2004 T2458 T2456 appos UK,NIBSC
R2005 T2459 T2456 punct ),NIBSC
R2006 T2460 T2454 cc and,PM1
R2007 T2461 T2465 det the,line
R2008 T2462 T2464 amod human,cell
R2009 T2463 T2464 compound myeloid,cell
R2010 T2464 T2465 compound cell,line
R2011 T2465 T2473 nsubjpass line,grown
R2012 T2466 T2465 appos U937,line
R2013 T2467 T2468 punct (,NIBSC
R2014 T2468 T2466 appos NIBSC,U937
R2015 T2469 T2468 punct ",",NIBSC
R2016 T2470 T2468 appos UK,NIBSC
R2017 T2471 T2468 punct ),NIBSC
R2018 T2472 T2473 auxpass were,grown
R2019 T2473 T2451 conj grown,A3
R2020 T2474 T2473 prep in,grown
R2021 T2475 T2479 amod complete,supplemented
R2022 T2476 T2479 nsubj RPMI,supplemented
R2023 T2477 T2479 nsubj 1640,supplemented
R2024 T2478 T2479 amod medium,supplemented
R2025 T2479 T2473 advcl supplemented,grown
R2026 T2480 T2479 prep with,supplemented
R2027 T2481 T2482 nummod 10,%
R2028 T2482 T2485 nmod %,serum
R2029 T2483 T2485 amod fetal,serum
R2030 T2484 T2485 amod bovine,serum
R2031 T2485 T2480 pobj serum,with
R2032 T2486 T2485 punct ",",serum
R2033 T2487 T2489 nummod 2,l-glutamine
R2034 T2488 T2489 compound mM,l-glutamine
R2035 T2489 T2485 appos l-glutamine,serum
R2036 T2490 T2489 cc and,l-glutamine
R2037 T2491 T2493 nummod 100,penicillin
R2038 T2492 T2493 amod U/ml,penicillin
R2039 T2493 T2489 conj penicillin,l-glutamine
R2040 T2494 T2485 appos streptomycin,serum
R2041 T2495 T2473 punct .,grown

sentences

Id Subject Object Predicate Lexical cue
T2312 0-234 Sentence denotes The human T cell lines A3.01 and PM1 (NIBSC, UK) and the human myeloid cell line U937 (NIBSC, UK) were grown in complete RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mM l-glutamine and 100 U/ml penicillin–streptomycin.
T32 0-234 Sentence denotes The human T cell lines A3.01 and PM1 (NIBSC, UK) and the human myeloid cell line U937 (NIBSC, UK) were grown in complete RPMI 1640 medium supplemented with 10% fetal bovine serum, 2 mM l-glutamine and 100 U/ml penicillin–streptomycin.

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T2317 0-3 DT denotes The
T2318 4-9 JJ denotes human
T2319 10-11 NN denotes T
T2320 12-16 NN denotes cell
T2321 17-22 NN denotes lines
T2322 23-28 NN denotes A3.01
T2323 29-32 CC denotes and
T2324 33-36 NN denotes PM1
T2325 37-38 -LRB- denotes (
T2326 38-43 NNP denotes NIBSC
T2327 43-44 -COMMA- denotes ,
T2328 45-47 NNP denotes UK
T2329 47-48 -RRB- denotes )
T2330 49-52 CC denotes and
T2331 53-56 DT denotes the
T2332 57-62 JJ denotes human
T2333 63-70 JJ denotes myeloid
T2334 71-75 NN denotes cell
T2335 76-80 NN denotes line
T2336 81-85 NN denotes U937
T2337 86-87 -LRB- denotes (
T2338 87-92 NNP denotes NIBSC
T2339 92-93 -COMMA- denotes ,
T2340 94-96 NNP denotes UK
T2341 96-97 -RRB- denotes )
T2342 98-102 VB denotes were
T2343 103-108 VB denotes grown
T2344 109-111 IN denotes in
T2345 112-120 JJ denotes complete
T2346 121-125 NN denotes RPMI
T2347 126-130 CD denotes 1640
T2348 131-137 NN denotes medium
T2349 138-150 VB denotes supplemented
T2350 151-155 IN denotes with
T2351 156-158 CD denotes 10
T2352 158-159 NN denotes %
T2353 160-165 JJ denotes fetal
T2354 166-172 JJ denotes bovine
T2355 173-178 NN denotes serum
T2356 178-179 -COMMA- denotes ,
T2357 180-184 NN denotes 2 mM
T2358 185-196 NN denotes l-glutamine
T2359 197-200 CC denotes and
T2360 201-209 NN denotes 100 U/ml
T2361 210-233 NN denotes penicillin–streptomycin
R1865 T2321 T2317 arg1Of lines,The
R1866 T2321 T2318 arg1Of lines,human
R1867 T2321 T2319 arg1Of lines,T
R1868 T2321 T2320 arg1Of lines,cell
R1869 T2322 T2323 arg1Of A3.01,and
R1870 T2323 T2321 arg1Of and,lines
R1871 T2323 T2325 arg1Of and,(
R1872 T2323 T2330 arg1Of and,and
R1873 T2324 T2323 arg2Of PM1,and
R1874 T2326 T2325 arg2Of NIBSC,(
R1875 T2326 T2327 arg1Of NIBSC,","
R1876 T2326 T2328 arg1Of NIBSC,UK
R1877 T2329 T2325 arg3Of ),(
R1878 T2330 T2342 arg1Of and,were
R1879 T2330 T2343 arg2Of and,grown
R1880 T2336 T2330 arg2Of U937,and
R1881 T2336 T2331 arg1Of U937,the
R1882 T2336 T2332 arg1Of U937,human
R1883 T2336 T2333 arg1Of U937,myeloid
R1884 T2336 T2334 arg1Of U937,cell
R1885 T2336 T2335 arg1Of U937,line
R1886 T2336 T2337 arg1Of U937,(
R1887 T2338 T2337 arg2Of NIBSC,(
R1888 T2338 T2339 arg1Of NIBSC,","
R1889 T2338 T2340 arg1Of NIBSC,UK
R1890 T2341 T2337 arg3Of ),(
R1891 T2343 T2342 arg2Of grown,were
R1892 T2343 T2344 arg1Of grown,in
R1893 T2348 T2344 arg2Of medium,in
R1894 T2348 T2345 arg1Of medium,complete
R1895 T2348 T2346 arg1Of medium,RPMI
R1896 T2348 T2347 arg1Of medium,1640
R1897 T2348 T2349 arg2Of medium,supplemented
R1898 T2349 T2350 arg1Of supplemented,with
R1899 T2351 T2352 arg1Of 10,%
R1900 T2355 T2351 arg1Of serum,10
R1901 T2355 T2353 arg1Of serum,fetal
R1902 T2355 T2354 arg1Of serum,bovine
R1903 T2355 T2356 arg1Of serum,","
R1904 T2356 T2359 arg1Of ",",and
R1905 T2358 T2356 arg2Of l-glutamine,","
R1906 T2358 T2357 arg1Of l-glutamine,2 mM
R1907 T2359 T2350 arg2Of and,with
R1908 T2361 T2359 arg2Of penicillin–streptomycin,and
R1909 T2361 T2360 arg1Of penicillin–streptomycin,100 U/ml